Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy

Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

Scott Antonia, Augusto Villegas, Davey B. Daniel et al. · New England Journal of Medicine · 2017 · 4.5K citations · Full text

Medicine, Oncology, Radiation Oncology +15

Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC

Scott Antonia, Augusto Villegas, Davey B. Daniel et al. · New England Journal of Medicine · 2018 · 2.8K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Neutrophil/lymphocyte ratio and its association with survival after complete resection in non–small cell lung cancer

Khaled M Sarraf, Elizabeth Belcher, Evgeny Raevsky et al. · Journal of Thoracic and Cardiovascular Surgery · 2008 · 569 citations · Full text

Medicine, Immunology, Oncology +10

The Etiology of Treatment-related Lymphopenia in Patients with Malignant Gliomas: Modeling Radiation Dose to Circulating Lymphocytes Explains Clinical Observations and Suggests Methods of Modifying the Impact of Radiation on Immune Cells

Susannah Yovino, Lawrence Kleinberg, Stuart A. Grossman et al. · Cancer Investigation · 2013 · 408 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Lymphopenia Association With Gross Tumor Volume and Lung V5 and Its Effects on Non-Small Cell Lung Cancer Patient Outcomes

Chad Tang, Zhongxing Liao, Daniel R. Gomez et al. · International Journal of Radiation Oncology*Biology*Physics · 2014 · 373 citations

Medicine, Hematology, Oncology +14